← FDA Drug Approvals (Drugs@FDA)
NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2026-08-04
Drug application
- FDA Application #
ANDA219334- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE
- Generic name
- Nicardipine Hydrochloride
- Active ingredients
- NICARDIPINE HYDROCHLORIDE
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- FRESENIUS KABI USA
- First approval
- 2026-08-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown